Drug-Coated Balloon-Based Intervention for De Novo Acute Myocardial Infarction.

ABSTRACT:

Purpose

Data on drug-coated balloon (DCB) treatment in acute myocardial infarction (AMI) are limited. We aimed to assess the efficacy and safety of DCB revascularization in percutaneous coronary intervention (PCI) in patients with de novo AMI.

Materials and methods

Three hundred twenty-nine patients with de novo AMI who were successfully treated with DCB-based PCI were retrospectively enrolled. Patients treated with DCB-based PCI were compared to propensity score-matched patients who underwent conventional PCI with second-generation drug-eluting stent (DES), using data from a DES registry. Both groups were followed over 2 years to assess net adverse cardiovascular events (NACE).

Results

The cumulative incidences of NACE [6.2% vs. 10.8%; hazard ratio (HR) (95% confiden

SUBMITTER: Her AY 

PROVIDER: S-EPMC12673656 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature